Cerebral apoplexy treatment medicament and preparation method thereof

Abstract

The invention relates to a cerebral apoplexy treatment medicament and a preparation method thereof. The cerebral apoplexy treatment medicament comprises, by weight proportion, 10-20 parts of radix notoginseng, 25-35 parts of radix salviae miltiorrhizae, 5-15 parts of flos carthami ,10-20 parts of Geosaurus, 10-20 parts of angelica sinensis, 10-20 parts of Sichuan lovage rhizome, 5-15 parts of peony root and 0.1-1 part of synthetic musk. With radix notoginseng and radix salviae miltiorrhizae as major ingredients, the cerebral apoplexy treatment medicament is used for treating cerebral apoplexy. Compared with other traditional Chinese medicine formulas, the cerebral apoplexy treatment medicament is more reliable in treating effect and safe with no evident side effects. The cerebral apoplexytreatment medicament is capable of promoting blood circulation to remove blood stasis, is used for cerebral thrombosis convalescence, and is used for treating symptoms of hemiplegia, wrying mouth andtongue, difficult speech, dark tongue, ecchymosis and the like.

Description

technical field [0001] The invention relates to the technical field of Chinese patent medicines, in particular to a medicine for treating cerebral apoplexy and a preparation method thereof. Background technique [0002] Stroke, also known as cerebral apoplexy, is currently the second leading cause of human death in the world. According to the third national death retrospective sampling survey completed in my country in 2004-2005, cerebrovascular disease has jumped to the top of the national cause of death. Stroke is also the disease with the highest disability rate of a single disease. The high morbidity, high mortality and high disability rate of this disease bring heavy burden and great misery to society, family and patients. [0003] Cerebral stroke is a group of acute cerebrovascular diseases with sudden onset and common feature of focal neurological deficit, among which the incidence of ischemic stroke accounts for 60% to 80%. About 1 / 4 to 1 / 3 of the patients died wit...

AI Technical Summary

Problems solved by technology

Although the diagnosis and treatment technology for stroke (recovery period) has made great progress in recent years and has greatly improved the prognosis of patients, there has been a lack of effective treatment for stroke (recovery period) for a long time. Therefore, there is an urgent need for A therapeutic drug that can be widely used, has a significant effect on stroke (recovery period), improves the quality of life of stroke (recovery period) patients, and has few side effects